Anzeige
Mehr »
Freitag, 12.09.2025 - Börsentäglich über 12.000 News
Diese Aktie sichert sich Exklusiv-Partnerschaft mit Babcock für Ukraine-Defence - Neubewertung voraus?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 874929 | ISIN: FR0000031577 | Ticker-Symbol: V16
Frankfurt
12.09.25 | 18:44
323,50 Euro
+0,31 % +1,00
Branche
Pharma
Aktienmarkt
CAC Mid 60
1-Jahres-Chart
VIRBAC SA Chart 1 Jahr
5-Tage-Chart
VIRBAC SA 5-Tage-Chart
RealtimeGeldBriefZeit
320,00333,0021:26

Aktuelle News zur VIRBAC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
VIRBAC Aktie jetzt für 0€ handeln
17:48Virbac: 2025 Half-year results111Solid revenue growth in the first half of 2025 of +5.6% at constant exchange rates and scopeAdjusted recurring operating income² of 18.3% as a ratio to revenue, in line with our expectations Down...
► Artikel lesen
17:34Virbac: Half-yearly financial report 2025145Please find attached 2025 Half-yearly financial report of Virbac Attachment Half-Yearly Financial Report_2025 (https://ml-eu.globenewswire.com/Resource/Download/c0cc...
► Artikel lesen
17:34Virbac: Public release of the Half-Year Financial Report at 30 June 2025.134The Group released and filed its 2025 half-year financial report with the French "Autorité des marchés financiers". The document is also available on the corporate website, at corporate.virbac.com...
► Artikel lesen
05.09.Virbac: Declaration of the number of shares and voting rights 07/20251
05.09.Virbac: Declaration of the number of shares and voting rights 08/20251
18.08.Virbac: Paul Martingell's compensation terms204The board of directors of Virbac specifies Paul Martingell's compensation terms as chief executive officer. The board of directors, acting upon the recommendation of the appointments and compensation...
► Artikel lesen
17.07.Virbac-Aktie legt zu: Umsatzwachstum im zweiten Quartal beschleunigt sich5
16.07.Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation1
04.07.Virbac: Declaration of the number of shares and voting rights 06/20251
19.06.VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025253Virbac announces the appointment of Paul Martingell as the chief executive officer of the Virbac group, effective September 1, 2025. Paul Martingell, 45, is recognized as a leader who has demonstrated...
► Artikel lesen
10.06.Virbac: Declaration of the number of share and voting rights 05/20252
07.05.Virbac: Declaration of the number of shares and voting rights 04/20251
28.04.Virbac: Public release of Virbac Annual Report at 31 December 20241
15.04.Virbac: In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope284In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope KEY FIGURESRevenue1st quarter 2025€375.2MGrowth at constant exchange rates and scope1+4.9%...
► Artikel lesen
09.04.Virbac: Declaration of the number of shares and voting rights 03/20251
17.03.Stifel raises Virbac stock rating to Buy, price target to EUR3905
13.03.Virbac: 2024 Annual results619Very strong revenues increase of 13.6% at constant exchange rates, driven by: dynamic organic growth (+7.5%) strategic contribution of our acquisitions (+6.1%) 2024 operating income2 at an...
► Artikel lesen
16.01.Virbac: Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%)570Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%) Press release issued on January 16, 2025 after market...
► Artikel lesen
03.12.24Virbac: Türkiye: Virbac acquires its companion animal distributor485On December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion animal health products. Present in Türkiye for over 20 years via various...
► Artikel lesen
17.10.24Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.475KEY FIGURES Revenue at the end of September €1 042.1M Growth at constant exchange rates and scope1 +8.6% includingcompanion animals +11.9% farm animals ...
► Artikel lesen
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1